Megan Brooks

News

Major Depression in Older Adults Tied to Risky Driving Behaviors

Author:: Megan Brooks

Publish date: January 6, 2025

The new findings highlight the importance of routine depression screening and “a pressing need” for targeted interventions....

News

Americans’ Top Causes of Anxiety Revealed

Author:: Megan Brooks

Publish date: December 30, 2024

The economy, gun violence, and hate crimes are high on the list.

News

New Guidance Recommends Metformin to Prevent Antipsychotic Weight Gain

Author:: Megan Brooks

Publish date: December 23, 2024

“At present, it is likely that metformin is underused and when used, it is likely to be started after the weight gain occurs.”

News

Most Effective Treatments for Adult ADHD Identified

Author:: Megan Brooks

Publish date: December 18, 2024

“These are quite reassuring data and certainly reinforce the role of medication as a treatment for ADHD.”

News

APA Updates Guidance on Borderline Personality Disorder

Author:: Megan Brooks

Publish date: December 13, 2024

The APA now recommends that a patient with BPD have a documented, comprehensive, and person-centered treatment plan and be engaged in a collaborati...

News

Do Risk-Reducing Surgeries Benefit BRCA Carriers With Early-Onset Breast Cancer History?

Author:: Megan Brooks

Publish date: December 12, 2024

New findings from a retrospective cohort study of 5290 patients with BRCA1 and/or BRCA2 mutations who were diagnosed with stages I-III breast ...

News

New Cancer Drugs: Do Patients Prefer Faster Access or Clinical Benefit?

Author:: Megan Brooks

Publish date: December 12, 2024

For cancer drugs that have confirmatory trial data, more than half don’t ultimately provide an overall survival or quality of life benefit.

News

Does Acalabrutinib Fit Into Frontline MCL Therapy?

Author:: Megan Brooks

Publish date: December 11, 2024

Patients with mantle cell lymphoma do not benefit from the addition of BTK inhibitor to standard induction therapy, a new s...

News

Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat Immune Thrombocytopenia

Author:: Megan Brooks

Publish date: December 10, 2024

Research on a new Bruton tyrosine kinase inhibitor brings hope of “significant progress” for treating a rare bleeding disorder.

News

Common Herbicide a Player in Neurodegeneration?

Author:: Megan Brooks

Publish date: December 9, 2024

In addition to a possible cancer risk, multiple reports have also suggested potential harmful effects of glyphosate exposure on the brain.

News

CRC Screening Uptake Rises in Adults Aged 45-49 Years

Author:: Megan Brooks

Publish date: November 27, 2024

Researchers compared changes in screening uptake among average-risk adults 45-49 years between a 20-month period before and a 20-month period after...

News

NCCN Expands Cancer Genetic Risk Assessment Guidelines

Author:: Megan Brooks

Publish date: November 22, 2024

The guidelines tell when genetic testing is recommended and what type of testing may be best.

News

Prostate Cancer: Has Active Surveillance Solved the Problem of Overtreatment?

Author:: Megan Brooks

Publish date: November 18, 2024

Researchers analyzed data on 243,928 men in the VA Health System with clinically localized prostate cancer diagnosed between 2000 and 2019.

News

How Do Novel CRC Blood Tests Fare Against Established Tests?

Author:: Megan Brooks

Publish date: November 18, 2024

Researchers estimated the clinical and economic impacts of emerging blood- and stool-based CRC screening tests with established alternatives.

News

Endoscopic Sleeve Gastroplasty Yields Durable Weight Loss at 10 Years

Author:: Megan Brooks

Publish date: November 18, 2024

Bariatric surgery remains the most effective therapy for management of obesity and improvement of comorbid conditions.